Literature DB >> 19864158

Epigenetic mechanisms in the development of type 2 diabetes.

Sara E Pinney1, Rebecca A Simmons.   

Abstract

Type 2 diabetes (T2D) is a disorder of complex genetics influenced by interactions between susceptible genetic loci and environmental perturbations. Intrauterine growth retardation is one such environmental perturbation linked to the development of T2D in adulthood. An abnormal metabolic intrauterine milieu affects fetal development by permanently modifying expression of key genes regulating beta-cell development (Pdx1) and glucose transport (Glut4) in muscle. Epigenetic regulation of gene expression is one mechanism by which genetic susceptibility and environmental insults can lead to T2D. Therefore, therapeutic agents targeting epigenetic gene regulation can ultimately be used to treat T2D; however, there is much to be learned about genome-wide epigenetic programming of health and disease before these therapies can be used in patient care. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864158      PMCID: PMC2848901          DOI: 10.1016/j.tem.2009.10.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  62 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation.

Authors:  D Schübeler; M C Lorincz; D M Cimbora; A Telling; Y Q Feng; E E Bouhassira; M Groudine
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 3.  Histone methylation in transcriptional control.

Authors:  Tony Kouzarides
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

4.  A high-resolution map of active promoters in the human genome.

Authors:  Tae Hoon Kim; Leah O Barrera; Ming Zheng; Chunxu Qu; Michael A Singer; Todd A Richmond; Yingnian Wu; Roland D Green; Bing Ren
Journal:  Nature       Date:  2005-06-29       Impact factor: 49.962

5.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

Authors:  H Sakuraba; H Mizukami; N Yagihashi; R Wada; C Hanyu; S Yagihashi
Journal:  Diabetologia       Date:  2002-01       Impact factor: 10.122

6.  Obesity at the age of 50 y in men and women exposed to famine prenatally.

Authors:  A C Ravelli; J H van Der Meulen; C Osmond; D J Barker; O P Bleker
Journal:  Am J Clin Nutr       Date:  1999-11       Impact factor: 7.045

7.  Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.

Authors:  H Kaneto; G Xu; K H Song; K Suzuma; S Bonner-Weir; A Sharma; G C Weir
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

8.  Intrauterine growth retardation leads to the development of type 2 diabetes in the rat.

Authors:  R A Simmons; L J Templeton; S J Gertz
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

9.  Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.

Authors:  D T Finegood; M D McArthur; D Kojwang; M J Thomas; B G Topp; T Leonard; R E Buckingham
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

10.  Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring.

Authors:  Craig A Cooney; Apurva A Dave; George L Wolff
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

View more
  71 in total

1.  Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.

Authors:  Tiangang Li; Jessica M Francl; Shannon Boehme; Adrian Ochoa; Youcai Zhang; Curtis D Klaassen; Sandra K Erickson; John Y L Chiang
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

Review 2.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

3.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

Review 4.  Epigenetics and developmental programming of adult onset diseases.

Authors:  Lee O'Sullivan; Alexander N Combes; Karen M Moritz
Journal:  Pediatr Nephrol       Date:  2012-12       Impact factor: 3.714

5.  Developmental regulation of inflammatory cytokine-mediated Stat3 signaling: the missing link between intrauterine growth restriction and pulmonary dysfunction?

Authors:  Miguel Angel Alejandre Alcazar; Iris Ostreicher; Sarah Appel; Eva Rother; Christina Vohlen; Christian Plank; Jörg Dötsch
Journal:  J Mol Med (Berl)       Date:  2012-01-21       Impact factor: 4.599

6.  Remembering development - epigenetic responses to fetal malnutrition.

Authors:  Alice S Green; Sean W Limesand
Journal:  J Physiol       Date:  2010-05-01       Impact factor: 5.182

7.  Pregnancy hormones boost beta cells via serotonin.

Authors:  Senta Georgia; Anil Bhushan
Journal:  Nat Med       Date:  2010-07       Impact factor: 53.440

Review 8.  The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives.

Authors:  Lei Chen; Dianna J Magliano; Paul Z Zimmet
Journal:  Nat Rev Endocrinol       Date:  2011-11-08       Impact factor: 43.330

Review 9.  Expansion of beta-cell mass in response to pregnancy.

Authors:  Sebastian Rieck; Klaus H Kaestner
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

10.  The association between chronic osteomyelitis and increased risk of diabetes mellitus: a population-based cohort study.

Authors:  S-Y Lin; C-L Lin; C-H Tseng; I-K Wang; S-M Wang; C-C Huang; Y-J Chang; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.